top of page
BioRN Team
Strategy & Mission
Strategy & Mission
BioRN Annual Conference 2018
BioRN Annual Conference 2018
HAE Visionary Seminar
Directory
Executive Board
Dr. Gitte Neubauer (Chair)
​
CEO of Cellzome GmbH - a GSK company, Heidelberg
Prof. Dr. Michael Boutros (Deputy Chair)
Head of Functional and Structural Genomics Program at the German Cancer Research Center (DKFZ), Heidelberg
Dean of Medical Faculty Heidelberg, University Heidelberg
Dr. André H.R. Domin
Managing Director of the Technologiepark Heidelberg GmbH, Heidelberg
Dr. Stefan Herr
CEO of EMBL Ventures GmbH, Heidelberg
Prof. Dr. Magnus von Knebel Doeberitz
Director, Department of Applied Tumor Biology, Institute of Pathology, University of Heidelberg
Dr. Volker Stadler
CEO of PEPperPRINT GmbH, Heidelberg
Dr. Axel Wiest
Chief Operating Officer R&D, Merck KGaA, Darmstadt
Prof. Dr. Adelheid Cerwenka
Professor and Chair of Immunobiochemistry, Vice Dean of Research,
Mannheim Institute for Innate Immunoscience (MI3), Heidelberg University, Medical Faculty Mannheim
Dr. Angelika Vlachou
Partner, High-Tech Gründerfonds Management GmbH (HTGF), Bonn
Marc Massoth
Head of Office for Business Development and Science, City of Heidelberg
Dr. Claus Kremoser
Chief Executive Officer & Executive Board,
WMT AG, Heidelberg
Dr. Volker Stadler
CEO of PEPperPRINT GmbH, Heidelberg
Strategic Advisory Board
The strategic board is an advisory body, endoursed with the task of advising the executive board particularly on strategic issues or reviewing executive board decisions.
Dr. Chistian Tidona (Chair), Managing Director BioMed X GmbH, Heidelberg
Dr. Jürgen Bauer, Deputy Managing Director, EMBLEM Technology Transfer GmbH, Heidelberg
Katja Betts, CEO PROGEN Biotechnik GmbH, Heidelberg
Dr. Ulrich Betz, Senior Vice President Innovation, Merck KGaA, Darmstadt
Dr. Siegfried Bialojan, Biotech Expert
Dr. Sophia Deil, CEO ScienceValue Heidelberg GmbH
Katharina Fox, Medical Technology Cluster Management, Mannheim
Dr. Jürgen Gamer, TET Systems GmbH
Dr. Jan Gradel, City of Heidelberg, Heidelberg
Martin Haag, Site Manager, Roche Diagnostics GmbH, Mannheim
Dr. Thomas Hanke, Evotec International GmbH, EVP, Head of Academic Partnerships, Hamburg
Prof. Dr. Carsten Hopf, Head of Institute for Instrumental Analytics and Bioanalytics Mannheim University of Applied Sciences
Andreas Kempff, Managing Director, Department of Industry, Innovation and Enterprise Promotion, Chamber of Industry and Commerce (IHK) Rhine-Neckar, Heidelberg
Dr. Bernd Nosse, Global Head BD&L Technologies and Research Beyond Boarders, Boehringer Ingelheim International GmbH, Ingelheim
Prof. Dr. Katja Patzel-Mattern, Vice President for Innovation and Transfer, Professor of Economic and Social History, Heidelberg University, Heidelberg
Dr. Martin Raditsch, CEO INNOVECTIS GmbH, Frankfurt am Main, General Partner CARMA FUND Management GmbH & CEO Innovectis GmbH
Dr. Kirstin Schilling, CEO INNOVECTIS GmbH, Frankfurt am Main
Dr. Oliver Schlüter, CEO/CFO Novaliq GmbH, Heidelberg
Dr. Joachim Vogt, Director Search & Evaluation Western Europe at AbbVie
Dr. Rainer Wessel, Director Innovation Management, German Cancer Research Center (DKFZ), Heidelberg
Prof. Dr. Heike Andrea Wieland, Director External Ecosystem R&D, Sanofi-Aventis Deutschland GmbH, Frankfurt am Main
Scientific Advisory Board
The Scientific Advisory Board is an advisory body entrusted with the task of advising the executive board particularly in the selection and evaluation of project ideas and projects
Prof. Dr. Mathias Hafner (Chair), Vice President for Research and Technology Transfer at Mannheim University of Applied Sciences
Prof. Dr. Bernd Bukau, Director of Zentrum für Molekulare Biologie Heidelberg (ZMBH)
Dr. Christoph Antz, CEO, VERAXA Biotech GmbH, Heidelberg
Prof. Dr. Magnus von Knebel Doeberitz, Medical Director, Department Head at University Hospital Heidelberg
Ralf Angermund M.D. Ph.D., Early Innovation Partnering Director Deutschland, Janssen-Cilag GmbH (Johnson & Johnson)
Prof. Dr. Sonja Loges, Director, W3 Professor, Department of Personalized Oncology, Director, Division of Personalized Medical Oncology, German Cancer Research Center (DKFZ), Heidelberg
Prof. Dr. Patrick Most, Head of the Molecular and Translational Cardiology Section, Heidelberg, CEO and Co-Founder AaviGen GmbH, Heidelberg
Prof. Dr. Nina Papavasiliou, Head of Division of Immune Diversity, German Cancer Research Center (DKFZ), Heidelberg
Prof. Dr. Michael Platten, Chairman Department of Neurology, Medical Faculty Mannheim, Heidelberg University; Head of Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg; Founder and Managing Director Tcelltech, Mannheim
Dr. Birgit Zech, CEO Anavo Therapeutics B.V., Leiden
Dr. Daniel Forler, Senior Director BD&L, New Platforms /OPH/HEM, Bayer AG, Berlin
Dr. Thomas Höger, CEO and co-founder, Apogenix GmbH, Heidelberg
Dr. Friedrich Rippmann, ex-Merck KGaA, Darmstadt
Prof. Dr. Andreas Trumpp, Managing Director of HI-STEM, Professor and Head of the Division of Stem Cell and Cancer at the DKFZ Heidelberg
bottom of page